FLAVONOIDS IMPACT ON PREVENTION AND TREATMENT OF OBESITY AND RELATED METABOLIC RISK FACTORS

Abstract

Metabolic syndrome, the most prevailing health concern worldwide, and their incidences are increasing at a very high rate, resulting in enormous social costs. Obesity is a measure risk factor for non-communicable disease such as cardiovascular diseases, diabetes, cancer, and inflammation-based diseases. Therapeutic strategies for managing this syndrome include synthetic drugs and surgery, which entail high costs and serious complications. Over the last decade, there has been an increase in the interest for the expansion of anti-obesity drugs, with particular attention paid to those from natural sources. Flavonoids or bioflavonoids derived from the Latin word flavus, mean yellow, and are ubiquitous in plants; these compounds are the most abundant polyphenolic compounds in the human diet and have been found to possess many beneficial effects with advantages over chemical treatments. Several clinical and research studies has suggested that flavonoids have been investigated in great depth and have shown a wide range of anti-inflammatory, anti-oxidant, anti-microbial and anti-cancer properties. Beneficial effects of dietary flavonoids on glucose homeostasis for the prevention and treatment of obesity and diabetes support the various in-vitro cell and in-vivo animal studies. Furthermore, well designed clinical trials are still needed to focus on both safety and efficacy of these flavonoids. In this paper, we have to summarize the current progress of the anti-obesity potential of natural flavonoids and their various mechanisms that target multiple molecular for preventing the cluster of diseases.

Authors and Affiliations

V. K. Jain et al.

Keywords

Related Articles

DEVELOPMENT AND VALIDATION OF A NEW HPLC-UV METHOD FOR SIMULTANEOUS ESTIMATION OF CETIRIZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE IN TABLET FORMULATION

A simple, rapid, and sensitive high-performance liquid chromatographic method with UV detection has been developed and validated according to the ICH guidelines for the quantitation of Cetirizine Hydrochloride (CET) and...

Evaluation of Antidiabetic Activity of Triumfetta Pilosa Roth in Streptozotocin-Induced Diabetic Rats

The present study aims to evaluate medicinal use of Triumfetta pilosa for the treatment of diabetes. Antidiabetic activity of ethanolic extract of Triumfetta Pilosa Roth was evaluated for in-vivo hypoglycemic activity u...

EFFECT OF PIPER NIGRUM (LINN.) ON INFERTILITY INDUCED BY ETHIONAMIDE AND PARA AMINO SALICYLIC ACID IN MALE SPRAGUE-DAWLEY RATS

Tuberculosis is a global problem. The tuberculosis is the common cause of male infertility in developing countries due to the use of second-line anti-tuberculosis drugs (ATB). The experiments were conducted at Unique Bio...

QbD BASED RP-HPLC METHOD DEVELOPMENT FOR FIVE FLUOROQUINOLONE ANTI-BACTERIALS - THROUGH CREATION OF DESIGN SPACE FOR CRITICAL ATTRIBUTES

Quality by Design (QbD) has become an important concept for the pharmaceutical industry, and ICH recommends this concept through the Guideline Q8 (R2) wherein if the method is proved to be rugged and robust within the li...

GENUS ALPINIA, A POTENTIAL POWERHOUSE OF BIOACTIVE: A REVIEW

Alpinia is the largest and most taxonomically complex genus in the Zingiberaceae family. This includes about 230 species and widely spread throughout forests in tropical and subtropical Asia. Many of species are herbs an...

Download PDF file
  • EP ID EP656715
  • DOI 10.13040/IJPSR.0975-8232.10(10).4420-29
  • Views 110
  • Downloads 0

How To Cite

V. K. Jain et al. (2019). FLAVONOIDS IMPACT ON PREVENTION AND TREATMENT OF OBESITY AND RELATED METABOLIC RISK FACTORS. International Journal of Pharmaceutical Sciences and Research (IJPSR), 10(10), 4420-4429. https://europub.co.uk/articles/-A-656715